SAN FRANCISCO, CA—A new variation of the CRISPR-Cas9 gene editing system makes it easier to re-engineer massive quantities of cells for therapeutic applications. The approach, developed at Gladstone ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. In an NBC News story about the reality gap between businesses talking about artificial ...

According to research by SNS Insider, the U.S. Viral Vector Manufacturing Market is projected to grow at a CAGR of 21.26%, driven by rapid expansion in gene therapy development, rising outsourcing to ...

Announcing a new article publication for Zoonoses journal. Vaccinia virus (VACV) confers cross-protective immunity against the variola virus, the causative agent of smallpox, and has therefore been ...